Inhibitors of hepatitis B virus covalently closed circular DNA formation and their method of use
US9657013B2 · kind B2 · utility
0Cited by
3References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 28, 2013 |
| Grant date | May 23, 2017 |
| Priority date | — |
| Expiry date | Feb 28, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.